Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001228509 | SCV001400910 | uncertain significance | Nemaline myopathy 2 | 2022-07-05 | criteria provided, single submitter | clinical testing | This sequence change falls in intron 34 of the NEB gene. It does not directly change the encoded amino acid sequence of the NEB protein. It affects a nucleotide within the consensus splice site. This variant is present in population databases (no rsID available, gnomAD 0.0009%). This variant has not been reported in the literature in individuals affected with NEB-related conditions. ClinVar contains an entry for this variant (Variation ID: 955805). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Revvity Omics, |
RCV003130202 | SCV003809627 | uncertain significance | not provided | 2019-04-25 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001228509 | SCV002077729 | uncertain significance | Nemaline myopathy 2 | 2020-10-19 | no assertion criteria provided | clinical testing |